State Immunization Information Systems to Improve HPV Vaccination Rates

Completed · Not applicable

Conditions studied: Vaccine, Human Papiloma Virus Vaccine, HPV Vaccine, Immunization, Health Registry, Adolescent Health, Reproductive Health, Preventive Health Services

In brief

The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve Human Papiloma Virus (HPV) vaccination rates among adolescents ages 11-17 (with a more focused look at the new two dose series for 11-14 year olds).

Key facts

Study ID

NCT02993965

Run by

University of Colorado, Denver

People needed

77716

Starts

2017-02-21

Expected to finish

2020-07-31

Last updated by the study team

2020-08-20

Who can join

Age: 11 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 11 through 17 years of age (trial 1)
• 11 through 14 years of age (trial 2)
• defaulted to our selected clinics within CIIS
• is either due for an HPV dose at baseline according to Advisory Committee on Immunization Practices (ACIP) guidelines, or
• has initiated but not yet completed the HPV series at baseline

You may not qualify if…

• Has completed the HPV vaccine series according to Advisory Committee on Immunization Practices (ACIP) guidelines
• Any child whose parents have requested removal from the immunization registry

Where it is running

• University of Colorado — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.